Oxford COVID-19 vaccine: DCGI asks Serum Institute to revise protocol for phase 2, 3 trials

3
Поделиться
Скопировать ссылку

A CDSCO expert panel has sought clarifications from Serum Institute of India (SII) over its application to the Drugs Controller General of India (DCGI) seeking …